Home LiteratureArticle Details
PMID: 10226887 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes.

Journal of clinical immunology ·Vol. 19 ·No. 2 ·1999-03-00 ·Pages 127-34

Dubois-LaForgue D, Carel JC, Bougnères PF, Guillet JG, Boitard C

Abstract

Insulin-dependent diabetes mellitus (IDDM) results from the selective destruction of pancreatic beta cells by a T cell-mediated autoimmune process. Insulin and proinsulin are the only known beta cell-specific autoantigens. Using short-term cultures of freshly isolated peripheral blood mononuclear cells, we evaluated T-cell responses to proinsulin and to insulin in IDDM patients and individuals at risk for IDDM. A proliferative T-cell response to proinsulin was observed in only 2 of 26 recent-onset IDDM subjects and 2 of 12 long-standing IDDM subjects and was associated with a proliferative response to insulin. In contrast, 5 of 13 islet cell autoantibody-positive first-degree relatives of IDDM patients showed a proliferative response to proinsulin alone, 3 of 13 to insulin alone, and 1 of 13 to both insulin and proinsulin. Overall, 9 of 13 ICA-positive first-degree relatives responded to either proinsulin or insulin. We observed an inverse relationship between antiinsulin antibodies and T-cell responses to insulin in ICA-positive first-degree relatives but not in long-standing IDDM patients. Our data indicate that proinsulin is a major antigen in IDDM and, further, illustrate the difference between the autoimmune response to insulin and the immune response to exogenous insulin.

MeSH Terms
Adolescent Adult Autoantibodies/blood Child Child, Preschool Diabetes Mellitus, Type 1/immunology HLA-DR Antigens/metabolism Humans Insulin/immunology Lymphocyte Activation Middle Aged Proinsulin/immunology T-Lymphocytes/immunology
Chemicals
Autoantibodies HLA-DR Antigens Insulin Proinsulin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dubois-LaForgue D
INSERM U342, Hôpital Saint-Vincent de Paul, Paris, France.
Carel J C
Bougnères P F
Guillet J G
Boitard C
References (50)
50 references, click to expand
  1. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Mol Med. 1995 Sep;1(6):625-33 PMID: 8529129
  2. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
    Eur J Immunol. 1995 Apr;25(4):1056-62 PMID: 7537670
  3. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.
    Cell. 1991 Sep 20;66(6):1145-53 PMID: 1913805
  4. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.
    Annu Rev Immunol. 1990;8:647-79 PMID: 2188676
  5. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.
    J Exp Med. 1987 Oct 1;166(4):823-32 PMID: 3309126
  6. The relationship between humoral and cellular immunity to IA-2 in IDDM.
    Diabetes. 1998 Apr;47(4):566-9 PMID: 9568688
  7. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs.
    J Clin Endocrinol Metab. 1997 Feb;82(2):375-80 PMID: 9024221
  8. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.
    J Clin Invest. 1992 Dec;90(6):2242-50 PMID: 1469084
  9. Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes.
    Diabetes. 1989 Oct;38(10):1320-5 PMID: 2676660
  10. Evidence for the effects of a superantigen in rheumatoid arthritis.
    Science. 1991 Jul 19;253(5017):325-9 PMID: 1857971
  11. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
    Lancet. 1990 Jan 20;335(8682):147-9 PMID: 1967440
  12. Cyclosporin A suppresses insulin autoantibodies and heterologous insulin antibodies in type I diabetic children.
    Diabetes. 1988 Aug;37(8):1049-52 PMID: 3292324
  13. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.
    J Clin Invest. 1995 Feb;95(2):628-34 PMID: 7860747
  14. The design of trials for prevention of IDDM.
    Diabetes. 1993 Jul;42(7):941-7 PMID: 7646584
  15. Single amino acid substitution alters T cell determinant selection during antigen processing of Staphylococcus aureus nuclease.
    J Immunol. 1991 Jan 15;146(2):438-43 PMID: 1702801
  16. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).
    Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):956-60 PMID: 8570667
  17. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
    Diabetes. 1996 Jul;45(7):926-33 PMID: 8666144
  18. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse.
    J Autoimmun. 1991 Apr;4(2):263-76 PMID: 1679332
  19. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse.
    Diabetes. 1997 Jul;46(7):1124-32 PMID: 9200646
  20. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.
    J Clin Invest. 1996 Jun 15;97(12):2772-83 PMID: 8675688
  21. Insulin prophylaxis in individuals at high risk of type I diabetes.
    Lancet. 1993 Apr 10;341(8850):927-8 PMID: 8096268
  22. Th1 and Th2 in human diseases.
    Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 1):225-35 PMID: 8811042
  23. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10252-6 PMID: 1946445
  24. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment.
    Diabetes. 1988 Jan;37(1):130-2 PMID: 3275554
  25. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
    Science. 1984 Mar 30;223(4643):1362-7 PMID: 6367043
  26. The pancreatic islets in diabetes.
    Am J Med. 1981 Jan;70(1):105-15 PMID: 7006384
  27. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Diabetes. 1993 Jan;42(1):44-55 PMID: 8093606
  28. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient.
    J Clin Invest. 1996 Jan 15;97(2):551-61 PMID: 8567980
  29. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    J Clin Invest. 1992 Apr;89(4):1161-5 PMID: 1556180
  30. Islet cell autoantigens in insulin-dependent diabetes.
    J Clin Invest. 1993 Oct;92(4):1608-16 PMID: 8408615
  31. Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA).
    Diabetes. 1987 Jan;36(1):66-72 PMID: 2431939
  32. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
    Lancet. 1993 May 29;341(8857):1365-9 PMID: 8098789
  33. Treatment of prediabetic patients with insulin: experience and future. European Prediabetes Study Group.
    Horm Res. 1996;45 Suppl 1:44-7 PMID: 8805030
  34. Cellular immune response to diverse islet cell antigens in IDDM.
    Diabetes. 1996 Jun;45(6):795-800 PMID: 8635655
  35. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.
    Nature. 1990 Sep 13;347(6289):151-6 PMID: 1697648
  36. Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice.
    Diabetologia. 1998 Feb;41(2):237-40 PMID: 9498660
  37. Influence of protein-quaternary structure on antigen processing.
    J Immunol. 1993 Feb 1;150(3):782-92 PMID: 7678622
  38. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).
    J Clin Invest. 1995 Sep;96(3):1506-11 PMID: 7657822
  39. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes.
    Lancet. 1992 Feb 22;339(8791):458-9 PMID: 1346821
  40. Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Held in New York, New York, October 1987.
    Diabetologia. 1988 Jul;31(7):451-2 PMID: 3065106
  41. Isohormonal therapy of endocrine autoimmunity.
    Immunol Today. 1995 Jun;16(6):289-94 PMID: 7662098
  42. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
    J Clin Invest. 1998 Jan 15;101(2):327-36 PMID: 9435304
  43. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone.
    Science. 1990 Sep 21;249(4975):1433-6 PMID: 2205920
  44. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Diabetes. 1994 Mar;43(3):459-67 PMID: 8314020
  45. Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones.
    J Immunol. 1989 Nov 1;143(9):2814-9 PMID: 2478626
  46. Insulin antibodies in insulin-dependent diabetics before insulin treatment.
    Science. 1983 Dec 23;222(4630):1337-9 PMID: 6362005
  47. Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus.
    J Autoimmun. 1990 Jun;3(3):321-7 PMID: 2204345
  48. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Diabetologia. 1997 May;40(5):564-72 PMID: 9165225
  49. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
    Diabetes. 1991 Sep;40(9):1128-33 PMID: 1936620
  50. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Diabetes. 1994 Nov;43(11):1304-10 PMID: 7926304
Article Info
Journal
Journal of clinical immunology
Abbr.
J Clin Immunol
ISSN
0271-9142
Published
1999-03-00
Pages
127-34
Language
English
Region
Netherlands
NLM ID
8102137
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com